KYTH News
Archived Headlines
- KYTHERA Biopharma sets terms for $60 million IPO 09/24/12
- Confidential US filings becoming frequent stop on IPO road 08/24/12
- US IPO filing activity reluctantly recovering since Facebook's IPO; Three US-based S-1 filings last week 06/11/12
- IPO activity remains slow despite Facebook offering 05/18/12
- KYTHERA Biopharmaceuticals files for a $86 million IPO 05/17/12
The LIPO IPO: Neothetics files to raise $63 million to fight fat with an asthma drug
Neothetics, a biotech targeting fat reduction with an injectable formulation of an approved asthma drug, filed on Friday with the SEC to raise up to $63 million in an initial public offering. Business The company has completed Phase 2 trials for...read more
Nine US IPO pricings cap busiest period since early 2011
Led by the blockbuster Workday (WDAY) and Realogy (RLGY) IPOs, all nine companies on the US IPO calendar priced this week, closing off a very active period in the...read more
KYTHERA Biopharma prices upsized deal at $16, at high end of the range
KYTHERA Biopharmaceuticals, which is commercializing an injectable treatment for double chins with Bayer, raised $70 million by offering 4.4 million shares at $16, at high end of the range of $14 to $16. The 4.4 million shares offered was 10% more than...read more
Shutterstock prices IPO at $17, above the range
Shutterstock (SSTK), an online marketplace for royalty-free images and videos, raised $77 million by offering 4.5 million shares at $17, above the range of $13 to $15. Shutterstock plans to list on the NYSE under the symbol SSTK. Morgan Stanley, Deutsche Bank...read more